2 Third Avenue Management Myriad Genetics Trades
Third Avenue Management started to build up the position in Myriad Genetics in Q4 2013. Since then they sold 328 Thousand shares. The investor sold all their shares in Q1 2014 and doesn't own any shares in Myriad Genetics anymore.
News about Myriad Genetics, Inc. and Third Avenue Management
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024
Management will also participate in four upcoming investor healthcare conferences Management will also participate in four upcoming investor healthcare confe...
Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. increased its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN) by 1.8% in the 2nd quarter, according to th...
Point72 Asset Management L.P. Sells 16,043 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Point72 Asset Management L.P. trimmed its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN) by 4.0% in the 2nd quarter, according to the company in its most re...